HUP0105279A2 - Javított stabilitású készítmények - Google Patents

Javított stabilitású készítmények

Info

Publication number
HUP0105279A2
HUP0105279A2 HU0105279A HUP0105279A HUP0105279A2 HU P0105279 A2 HUP0105279 A2 HU P0105279A2 HU 0105279 A HU0105279 A HU 0105279A HU P0105279 A HUP0105279 A HU P0105279A HU P0105279 A2 HUP0105279 A2 HU P0105279A2
Authority
HU
Hungary
Prior art keywords
liquid
preparations
compositions
improved stability
dispensing devices
Prior art date
Application number
HU0105279A
Other languages
English (en)
Inventor
Douglas Joseph Dobrozsi
Original Assignee
The Procter & Gamble Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Co. filed Critical The Procter & Gamble Co.
Publication of HUP0105279A2 publication Critical patent/HUP0105279A2/hu
Publication of HUP0105279A3 publication Critical patent/HUP0105279A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát javított gyógyászati hatóanyag szállításúkészítmények képezik. Ezek a készítmények egy oldószerben levőgyógyászati hatóanyagot tartalmaznak. Ezen készítmények szájbahelyezett, és esetenként lenyelt folyékony elixír formáját vehetikfel, vagy folyadék töltetű pasztillákon, cseppeken, kimért folyadékotadagoló eszközökön, porlasztókon és folyadék-kibocsátó eszközökön,ehető kapszulákon keresztül adagolhatók. Ó
HU0105279A 1999-01-11 2000-01-10 Compositions having improved stability HUP0105279A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11537899P 1999-01-11 1999-01-11
US15653999P 1999-09-29 1999-09-29

Publications (2)

Publication Number Publication Date
HUP0105279A2 true HUP0105279A2 (hu) 2002-05-29
HUP0105279A3 HUP0105279A3 (en) 2003-05-28

Family

ID=26813132

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105279A HUP0105279A3 (en) 1999-01-11 2000-01-10 Compositions having improved stability

Country Status (16)

Country Link
US (1) US20020086878A1 (hu)
EP (1) EP1143973A2 (hu)
JP (1) JP2002534462A (hu)
KR (1) KR20010093256A (hu)
CN (1) CN1346270A (hu)
AU (1) AU3344900A (hu)
BR (1) BR0007428A (hu)
CA (1) CA2360358A1 (hu)
CO (1) CO5430216A1 (hu)
CZ (1) CZ20012493A3 (hu)
HU (1) HUP0105279A3 (hu)
ID (1) ID30508A (hu)
NO (1) NO20013440L (hu)
PE (1) PE20001397A1 (hu)
TR (1) TR200101929T2 (hu)
WO (1) WO2000041692A2 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60309440T2 (de) 2002-02-08 2007-10-11 The Procter & Gamble Company, Cincinnati Kindersichere verpackung
US20040028622A1 (en) * 2002-08-12 2004-02-12 Michael Gurin Multifunctional flavor systems and method of use
AU2003299659A1 (en) 2002-12-13 2004-07-09 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
US20070059417A1 (en) * 2005-09-15 2007-03-15 Moza Ashok K Cooling agents as flavor and saltiness enhancers
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
FR2910317B1 (fr) 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
EP2219622A1 (en) 2007-12-06 2010-08-25 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
US9572885B2 (en) 2013-03-15 2017-02-21 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
WO2018183203A1 (en) * 2017-03-27 2018-10-04 DXM Pharmaceutical, Inc. Packaged multi-dose liquid drug formulation
US11234897B2 (en) 2017-03-27 2022-02-01 DXM Pharmaceutical, Inc. Packaged multi-dose liquid dextromethorphan hydrobromide formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
CA2181241C (en) * 1994-01-24 2000-04-25 Dadi Jamshed Dhabhar Process for solubilizing difficultly soluble pharmaceutical actives
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids

Also Published As

Publication number Publication date
EP1143973A2 (en) 2001-10-17
CN1346270A (zh) 2002-04-24
WO2000041692A3 (en) 2000-11-30
CO5430216A1 (es) 2004-06-01
AU3344900A (en) 2000-08-01
BR0007428A (pt) 2002-10-15
JP2002534462A (ja) 2002-10-15
US20020086878A1 (en) 2002-07-04
CZ20012493A3 (cs) 2001-11-14
TR200101929T2 (tr) 2001-12-21
NO20013440L (no) 2001-09-11
HUP0105279A3 (en) 2003-05-28
NO20013440D0 (no) 2001-07-11
CA2360358A1 (en) 2000-07-20
KR20010093256A (ko) 2001-10-27
ID30508A (id) 2001-12-13
PE20001397A1 (es) 2000-12-21
WO2000041692A2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
HUP0105021A2 (hu) Javított hatóanyag-kibocsátású készítmények és eljárás az előállításukra
HUP0202797A2 (hu) Javított stabilitású készítmények
HUP0105279A2 (hu) Javított stabilitású készítmények
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
WO2005046640A3 (en) Multi-site drug delivery platform
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
ATE401892T1 (de) Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand
DK1589945T3 (da) Topisk farmaceutisk og/eller kosmetisk dispenseringssystem
HUP0102468A2 (hu) Nyomás alatti dózisadagoló inhaláló berendezés és aeroszol formájú gyógyászati készítmények
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
YU59899A (sh) Medicinski aerosolni proizvodi
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
HK1083200A1 (en) Pharmaceutical preparations for oral administration, containing ion- exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
WO2007109684A3 (en) Dose packaging system for load-dose titration administration of a liquid formulation
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
EP1757269A3 (en) Pulmonary formulation comprising silicon particles
ZA985392B (en) New derivatives of 2-(iminomethyl) amino-phenyl, their preparation their use as medicaments and the pharmaceutical compositions containing them
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
ZA982203B (en) New derivatives of 2-(iminomethyl)amino-phenyl their preparation their use as medicaments and the pharmaceutical compositions containing them
SG149054A1 (en) Multiparticulate formulations for oral delivery
HUP0105028A2 (hu) Javított stabilitású készítmények és eljárás az előállításukra
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
FR2796287B1 (fr) Dispositif d'administration de medicament
DE60025264D1 (de) Dosierbehälter für pulverförmige medikamente